Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Clinical trial NCT00104273 · COMPLETED
Trial details
- NCT number
- NCT00104273
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2007-03-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.